RoActemra
What is this? RoActemra is a medicine used for arthritis and some other conditions. It comes as a shot or liquid for a drip.
What's happening? There was a short supply of RoActemra in the EU. The problem has now been fixed.
Does this affect me? If you take RoActemra, check with your pharmacist or doctor. They can help you continue safely.
What should I do? Talk to your pharmacist or doctor before changing anything. They will guide you best.
🤖 Denne letforståelige oversigt er automatisk genereret ud fra den officielle meddelelse fra myndigheden ved hjælp af AI. Den er udelukkende til generel information — ikke medicinsk rådgivning. Vedrørende beslutninger om din sundhed, skal du altid konsultere en farmaceut eller læge og læse den officielle kilde, der er linket nedenfor.
📋 Fra den officielle meddelelse fra myndigheden
Opdateret for 1 uge siden- Senest opdateret
- 01/04/2025
- Først udgivet
- 03/09/2021
- Berørte lægemidler
- RoActemra
- Berørte styrker
- 162 mg (syringe, pen) 20 mg/ml (concentrate)
- Lagerstatus
- Resolved
- Terapirigt område (MESH)
- Arthritis, RheumatoidArthritis, Juvenile RheumatoidCytokine Release SyndromeGiant Cell ArteritisCOVID-19 virus infection
- Tilgængelighed af alternativer
- Yes
- Berørte lægemiddelformer
- Pre-filled syringePre-filled penSolution for subcutaneous injectionConcentrate for solution for infusion
- Internationalt ikke-ejendomsretligt navn (INN) eller fællesnavn
- tocilizumab
Sideindhold
Mangel på lager
The shortage affecting RoActemra has been resolved and the information and recommendations which were issued during the shortage no longer apply.
Nøgleoplysninger
- Medicines affected
- RoActemra
- Supply shortage status
- Resolved
- International non-proprietary name (INN) or common name
- tocilizumab
- Therapeutic area (MESH)
- Arthritis, Rheumatoid
- Arthritis, Juvenile Rheumatoid
- Cytokine Release Syndrome
- Giant Cell Arteritis
- COVID-19 virus infection
- Pharmaceutical forms affected
- Pre-filled syringe
- Pre-filled pen
- Solution for subcutaneous injection
- Concentrate for solution for infusion
- Strengths affected
- 162 mg (syringe, pen)
- 20 mg/ml (concentrate)
- Availability of alternatives
- Yes
Nøgledatoer
- First published
- Last updated
Relateret medicinsk information
Direkte kommunikation til sundhedspersonale vedrørende denne mangel
- RoActemra - direct healthcare professional communication (DHPC)
🔬 Medicinske/tekniske detaljer Til fagfolk
INN: tocilizumab · Forms: Pre-filled syringe;Pre-filled pen;Solution for subcutaneous injection;Concentrate for solution for infusion · Strengths: 162 mg (syringe, pen) ;20 mg/ml (concentrate) · Area: Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection · Alternatives: Yes
Alle oplysninger på denne side stammer fra den officielle meddelelse fra myndighederne. Vi oversætter og opsummerer den; vi tilføjer eller redigerer ikke fakta.